The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $9.06 in the prior trading day, Mind Medicine Inc (NASDAQ: MNMD) closed at $9.23, up 1.88%. In other words, the price has increased by $1.88 from its previous closing price. On the day, 1.01 million shares were traded. MNMD stock price reached its highest trading level at $9.25 during the session, while it also had its lowest trading level at $8.7.
Ratios:
Our goal is to gain a better understanding of MNMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.98 and its Current Ratio is at 4.98. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On December 20, 2024, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $20.Chardan Capital Markets initiated its Buy rating on December 20, 2024, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 25 ’25 when Sullivan Mark sold 11,491 shares for $6.80 per share. The transaction valued at 78,139 led to the insider holds 305,130 shares of the business.
Karlin Daniel sold 7,848 shares of MNMD for $53,366 on Jun 25 ’25. The Chief Medical Officer now owns 438,329 shares after completing the transaction at $6.80 per share. On Jun 25 ’25, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, sold 26,491 shares for $6.80 each. As a result, the insider received 180,139 and left with 830,065 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 702291328 and an Enterprise Value of 560489728.
Stock Price History:
The Beta on a monthly basis for MNMD is 3.27, which has changed by 0.5525652 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $11.02, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is 3.53%, while the 200-Day Moving Average is calculated to be 23.60%.
Shares Statistics:
The stock has traded on average 1.22M shares per day over the past 3-months and 1341360 shares per day over the last 10 days, according to various share statistics. A total of 75.80M shares are outstanding, with a floating share count of 72.52M. Insiders hold about 4.01% of the company’s shares, while institutions hold 54.47% stake in the company. Shares short for MNMD as of 1755216000 were 10293064 with a Short Ratio of 8.40, compared to 1752537600 on 11224668. Therefore, it implies a Short% of Shares Outstanding of 10293064 and a Short% of Float of 13.63.
Earnings Estimates
Mind Medicine Inc (MNMD) is currently under the scrutiny of 7.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.43 and low estimates of -$0.63.
Analysts are recommending an EPS of between -$1.61 and -$1.95 for the fiscal current year, implying an average EPS of -$1.77. EPS for the following year is -$1.85, with 8.0 analysts recommending between -$1.0 and -$2.47.
